Aortic Valve Disease

  • Corrado Tamburino
  • Gian Paolo Ussia


Aortic stenosis (AS) is an obstruction to blood ejection from the left ventricle (LV) due to a fixed or dynamic stenosis located in the valve either over (supravalvular) or below it (subvalvular) [1].


Aortic Valve Aortic Stenosis Aortic Regurgitation Transcatheter Aortic Valve Implantation Left Ventricle Outflow Tract 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rahimtoola SH. Aortic valve disease. In: Fuster V, Alexander RW, O’Ruourke RA (eds) Hurst’s the heart (11th edn). New York: McGraw Hill, 2004; pp 1987–2000.Google Scholar
  2. 2.
    Alpert JS. Aortic stenosis: a new face for an old disease. Arch Intern Med 2003;163:1769–1770.PubMedGoogle Scholar
  3. 3.
    Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2006;48:1–148.Google Scholar
  4. 4.
    Tobin JR Jr, Rahimtoola SH, Blundell PE et al. Percentage of left ventricular stroke work loss: a simple hemodynamic concept for estimation of severity in valvular aortic stenosis. Circulation 1967;35:868–879.PubMedGoogle Scholar
  5. 5.
    Hess OM, Villari B, Krayenbuehl HP. Diastolic dysfunction in aortic stenosis. Circulation 1993;87:73–76.Google Scholar
  6. 6.
    Braunwald E, Fraham CJ. Studies on the Starling’s law of the heart. IV. Observations on hemodynamic functions of the left atrium in man. Circulation 1961;24:633–642.Google Scholar
  7. 7.
    Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Des 1976;18:255–264.Google Scholar
  8. 8.
    Johnson LL, Sciacca RR, Ellis K et al. Reduced left ventricular myocardial blood flow per unit mass in aortic stenosis. Circulation 1978;57:582–590.PubMedGoogle Scholar
  9. 9.
    Marcus ML, Doty DB, Horatzka LF et al. Decreased coronary reserve. A mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med 1982;46:1362–1366.Google Scholar
  10. 10.
    Gould KL, Carabello BA. Why angina in aortic stenosis with normal coronary arteriograms? Circulation 2003;107:3121–3123.PubMedGoogle Scholar
  11. 11.
    Chambers BJ. Aortic stenosis. Eur J Echocardiogr 2009;10:i11–i19.PubMedGoogle Scholar
  12. 12.
    Baumgartner H, Hung J, Bermejo J et al. Echocardiographic assessment of valve stenosis: EAE/ASE reccomandations for clinical practice. Eur J Echocardiogr 2009;10:1–25.PubMedGoogle Scholar
  13. 13.
    Smith MD, Kwan OL, DeMaria AN. Value and limitations of continuous-wave Doppler echocardiography in estimating severity of valvular stenosis. J Am Med Assoc 1986;255:3145–3151.Google Scholar
  14. 14.
    Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2006;48:e1–e148.PubMedGoogle Scholar
  15. 15.
    Vahanian A, Baumgartner H, Bax J et al, Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; ESC Committee For Practice Guidelines. Guidelines on the management of valvular heart disease. Eur Heart J 2007;28:230–268.PubMedGoogle Scholar
  16. 16.
    Otto CM, Pearlman AS, Comess KA et al. Determination of the stenotic aortic valve area in adults using Doppler echocardiography. J Am Coll Cardiol 1986;7: 509–517.PubMedGoogle Scholar
  17. 17.
    Razzolini R, Tarantini G. Quando è critica una stenosi valvolare?. Ital Heart J Suppl 2002;3:767–769.PubMedGoogle Scholar
  18. 18.
    Otto CM, Pearlman AS, Kraft CD et al. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J Am Coll Cardiol 1992;20:1160–1167.PubMedGoogle Scholar
  19. 19.
    Oh JK, Taliercio CP, Holmes DR Jr et al. Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol 1988;11:1227–1234.PubMedGoogle Scholar
  20. 20.
    De Filippi CR, DuWayne LW, Brickner ME et al. Usefulness of dobutamine echocardiography in distinguishing severe from non severe valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995;75:192–194.Google Scholar
  21. 21.
    Takeda S, Rimington H, Chambers J. The relation between transaortic pressure difference and flow during dobutamine stress echocardiography in patients with aortic stenosis. Heart 1999;82:11–14.PubMedGoogle Scholar
  22. 22.
    Otto MC. Valvular aortic stenosis. Disease severity and timing of intervention. J Am Coll Cardiol 2006;47:2141–2151.PubMedGoogle Scholar
  23. 23.
    Monin JL, Quere JP, Monchi M et al. Low-gradient aortic stenosis. Operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003;108:319–324.PubMedGoogle Scholar
  24. 24.
    Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005;26:1309–1313.PubMedGoogle Scholar
  25. 25.
    Popoviç A. Time-related trends in the preoperative evaluation of patients with valvular stenosis. Am J Cardiol 1997;80:1464–1468.PubMedGoogle Scholar
  26. 26.
    Baim DS. Grossman’s cardiac catheterization, angiography and intervention (7th edn). Philadelphia: Lipincott Williams and Wilkins, 2006.Google Scholar
  27. 27.
    Hakke AH. A simplified valve formula for the calculation of stenotic valve areas. Circulation 1981;63:1050–1055.Google Scholar
  28. 28.
    Bache RJ, Jorgensen CR, Wany Y. Simplified estimation of aortic valve area. Br Heart J 1972;34:408–411.PubMedGoogle Scholar
  29. 29.
    Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316–3326.PubMedGoogle Scholar
  30. 30.
    Otto CM, Burwash IG, Legget ME et al. A prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262–2270.PubMedGoogle Scholar
  31. 31.
    Rosenhek R, Klaar U, Schemper M et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199–205.PubMedGoogle Scholar
  32. 32.
    Pellikka PA, Sarano ME, Nishimura RA et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290–3295.PubMedGoogle Scholar
  33. 33.
    Chart Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968;38(Suppl 1):61–67.Google Scholar
  34. 34.
    Lancellotti P, Lebois F, Simon M et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005;112:I377–1382.PubMedGoogle Scholar
  35. 35.
    Astor BC, Kaczmarek RG, Hefflin B, Daley WR. Mortality after aortic valve replacement: results from a nationally representative database. Ann Thorac Surg 2000;70:1939–1945.PubMedGoogle Scholar
  36. 36.
    Culliford AT, Galloway AC, Colvin SB et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol 1991;67:1256–1260.PubMedGoogle Scholar
  37. 37.
    Shroyer AL, Coombs LP, Peterson E et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003;75:1856–1865.PubMedGoogle Scholar
  38. 38.
    Roques F, Nashef SA, Michel P et al. EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001;10:572–577.PubMedGoogle Scholar
  39. 39.
    Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular disease. Eur Heart J 2003;24:1231–1243.PubMedGoogle Scholar
  40. 40.
    Vahanian A, Alfieri O, Al-Attar et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;11:1463–1470.Google Scholar
  41. 41.
    Descoutures F, Himbert D, Lepage L et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J 2008;29:1410–1417.PubMedGoogle Scholar
  42. 42.
    Tops LF, Wood DA, Delgado V et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2008;1:321–330.PubMedGoogle Scholar
  43. 43.
    Ng AC, Delgado V, van der Kley F et al. before and after transcatheter aortic valve implantation by 2-and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging. 2010;3:94–102.PubMedGoogle Scholar
  44. 44.
    Delgado V, Ng AC, Van de Veire NR et al. Transcatheter aortic valve implantation: role of multi-detector row computed tomography to evaluate prosthesis positioning and deployment in relation to valve function. Eur Heart J 2010; 19 Feb, epub ahead of print.Google Scholar
  45. 45.
    Messika-Zeitoun D, Serfaty JM, Brochet E et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol. 2010;55:186–194.PubMedGoogle Scholar
  46. 46.
    Cribier A, Sabin T, Saoudi N et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement?. Lancet 1986;1:63–67.PubMedGoogle Scholar
  47. 47.
    McKay RG, Safian RD, Lock JE et al. Balloon dilatation of calcific aortic stenosis in elderly patients: post mortem, intraoperative, and percutaneous valvuloplasty studies. Circulation 1986;74:119–125.PubMedGoogle Scholar
  48. 48.
    Block PC, Palacios IF. Clinical and hemodynamic follow-up after percutaneous aortic valvuloplasty in the elderly. Am J Cardiol 1988;62:760–763.PubMedGoogle Scholar
  49. 49.
    Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994;89:642–650.PubMedGoogle Scholar
  50. 50. NHLBI Balloon Valvuloplasty Registry Participants. Percutaneous balloon aortic valvuloplasty: acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation 1991;84:2383–2397.Google Scholar
  51. 51.
    Zimrin DA, Reyes PA, Miller KL et al. Heart failure and “inoperable” aortic stenosis: staged balloon aortic valvuloplasty and aortic valve bypass. Congest Heart Fail 2008;14:211–213.PubMedGoogle Scholar
  52. 52.
    Iung B, Cachier A, Baron G et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J 2005;26:2714–2720.PubMedGoogle Scholar
  53. 53.
    Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704–708.PubMedGoogle Scholar
  54. 54.
    Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006–3008.PubMedGoogle Scholar
  55. 55.
    Grube E, Laborde JC, Zickmann B et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005;66:465–469.PubMedGoogle Scholar
  56. 56.
    Cribier A, Eltchaninoff H, Tron C et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698–703.PubMedGoogle Scholar
  57. 57.
    Cribier A, Eltchaninoff H, Tron C et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214–1223.PubMedGoogle Scholar
  58. 58.
    Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842–850.PubMedGoogle Scholar
  59. 59.
    Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755–763.PubMedGoogle Scholar
  60. 60.
    Webb JG, Altwegg L, Boone RH et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009;119:3009–3016.PubMedGoogle Scholar
  61. 61.
    Webb JG, Altwegg L, Masson JB et al. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009;53:1855–1858.PubMedGoogle Scholar
  62. 62.
    Nietlispach F, Wijesinghe N, Wood D et al. Current balloon-expandable transcatheter heart valve and delivery systems. Catheter Cardiovasc Interv 2010;75:295–300.PubMedGoogle Scholar
  63. 63.
    Lichtenstein SV, Cheung A, Ye J et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591–596.PubMedGoogle Scholar
  64. 64.
    Ye J, Cheung A, Lichtenstein SV et al. Six month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg 2007;31:16–21.PubMedGoogle Scholar
  65. 65.
    Walther T, Simon P, Dewey T et al. Transapical minimally invasive aortic valve implantation. Multicenter experience. Circulation 2007;116(Suppl I):1240–1245.Google Scholar
  66. 66.
    Svensson LG, Dewey T, Kapadia S et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008;86:46–55.PubMedGoogle Scholar
  67. 67.
    Ye J, Cheung A, Lichtenstein SV et al. Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients. J Thorac Cardiovasc Surg 2009;137:167–173.PubMedGoogle Scholar
  68. 68.
    Grube E, Laborde JC, Gerckens U et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006;114:1616–1624.PubMedGoogle Scholar
  69. 69.
    Grube E, Schuler G, Buellesfeld L et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69–76.PubMedGoogle Scholar
  70. 70.
    Grube E, Buellesfeld L, Mueller R et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving System. Circ Cardiovasc Interv 2008;1:167–175.PubMedGoogle Scholar
  71. 71.
    Piazza N, Grube E, Gerckens U et al. On the behalf of the clinical centres who actively participated in the registry. Procedural and 30-day outcomes following transcatheter aortic-valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded-evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242–249.PubMedGoogle Scholar
  72. 72.
    Tamburino C, Capodanno D, Mulè M et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. Journal Invasive Cardiol 2009;21:93–98.Google Scholar
  73. 73.
    Bleiziffer S, Ruge H, Mazzitelli D et al. Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur J Cardiothorac Surg 2009;35:615–620.PubMedGoogle Scholar
  74. 74.
    Fraccaro C, Napodano M, Tarantini G et al. Expanding the eligibility for transcatheter aortic valve implantation: the trans-subclavian retrograde approach using the III generation CoreValve Revalving System. J Am Coll Cardiol Intv 2009;2:828–833.Google Scholar
  75. 75.
    Ussia GP, Mulè M, Barbanti M et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 2009;30:1790–1796.PubMedGoogle Scholar
  76. 76.
    Buellesfeld L, Wenaweser P, Gerckens U et al. Transcatheter aortic valve implantation: predictors of procedural success — the Siegburg-Bern experience. Eur Heart J 2009; 27 Dec, epub ahead of print.Google Scholar
  77. 77.
    Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv 2008;71:579–584.PubMedGoogle Scholar
  78. 78.
    Low RI, Bolling SF, Yeo KK, Ebner A. Direct flow percutaneous aortic valve: proof of concept. Eurointerventions 2008;4:256–261.Google Scholar
  79. 79.
    Schofer J, Schlüter M, Treede H et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ Cardiovasc Interv 2008;1:126–133.PubMedGoogle Scholar
  80. 80.
    Cannon LA. AorTx: the low profile self-expanding valve. Presented at Transcatheter Cardiovascular Therapeutics (CTC) Congress, 2008, Washington DC, USA, October 13. 2008.
  81. 81.
    Figullas HR: The jena valve aortic leaflet clip concept. Presented at Transcatheter Cardiovascular Therapeutics (CTC) Congress, September 25, 2009, San Francisco.
  82. 82.
    Lauten A, Ferrari M, Petri A et al. Experimental evaluation of the JenaClip transcatheter aortic valve. Circ Cardiovasc Interv 2009;74:514–519.Google Scholar
  83. 83.
    Falk V, Schwammenthal EE, Kempfert J et al. New anatomically oriented transapical aortic valve. Ann Thorac Surg 2009;87:925–926.PubMedGoogle Scholar
  84. 84.
    Masson JB, Kovac J, Schuler G et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. J Am Coll Cardiol Interv 2009;2:811–820.Google Scholar
  85. 85.
    Ussia GP, Mulè M, Tamburino C. The valve-in-valve technique: transcatheter treatment of aortic bioprosthesis mal position. Catheter Cardiovasc Interv 2009;73:713–716.PubMedGoogle Scholar
  86. 86.
    Piazza N, Schultz C, de Jaegere P, Serruys PW. Implantation of two self-expanding aortic bioprosthesis valves during the same procedure? Insight into valve-in-valve implantation (“Russian Doll” concept). Catheter Cardiovasc Interv 2009;73:530–553.PubMedGoogle Scholar
  87. 87.
    Piazza N, Onuma Y, Jesserun E et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008;1:310–316.PubMedGoogle Scholar
  88. 88.
    Sinhal A, Altwegg L, Pasupati S et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv 2008;1:305–309.PubMedGoogle Scholar
  89. 89.
    Calvi V, Puzzangara E, Pruiti GP et al. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 2009;32 (Suppl 1):S126–130.PubMedGoogle Scholar
  90. 90.
    Jilaihawi H, Chin D, Vasa-Nicotera M et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009;157:860–866.PubMedGoogle Scholar
  91. 91.
    Tzikas A, Schultz C, Piazza N et al. Perforation of the membranous interventricular septum after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2009;2:582–583.PubMedGoogle Scholar
  92. 92.
    Braunwald E, Goldman L. Primary Cardiology (2nd edn). New York: Elsevier Science, 2003.Google Scholar
  93. 93.
    Mihaljevic Ti, Sayeed MR, Stamou SC, Paul S. Pathophysiology of aortic valve disease. In: Cohn LH, ed. Cardiac surgery in the adult. New York: McGraw-Hill, 2008, pp 825–840.Google Scholar
  94. 94.
    Braunwald E, Fauci AS, Kasper DL et al. Harrison’s principles of internal medicine (15th edn). New York: McGraw Hill, 2002.Google Scholar
  95. 95.
    Zoghbi WA, Chambers JB, Dumesnil JG et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr 2009;22:975–1014.PubMedGoogle Scholar
  96. 96.
    Zoghbi WA, Eriquez-Sarano M, Foster E et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777–802.PubMedGoogle Scholar
  97. 97.
    Perry GJ, Helmcke F, Nanda NC et al. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol 1987;9:952–959.PubMedGoogle Scholar
  98. 98.
    Tribouilloy CM, Enriquez-Sarano M, Fett SL et al. Application of the proximal flow convergence method to calculate the effective regurgitant orifice area in aortic regurgitation. J Am Coll Cardiol 1998;32:1032–1039.PubMedGoogle Scholar
  99. 99.
    Enriquez-Sarano M, Bailey KR, Seward JB et al. Quantitative Doppler assessment of valvular regurgitation. Circulation 1993;87:841–848.PubMedGoogle Scholar
  100. 100.
    Teague SM, Heinsimer JA, Anderson JL et al. Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound. J Am Coll Cardiol 1986;8:592–599.PubMedGoogle Scholar
  101. 101.
    Bonow RO. Chronic aortic regurgitation. Role of medical therapy and optimal timing for surgery. Cardiol Clin 1998;16:449.PubMedGoogle Scholar
  102. 102.
    Borer JS, Hochreiter C, Herrold EM et al. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 1998;97:525–534.PubMedGoogle Scholar
  103. 103.
    Tarasoutchi F, Grinberg M, Spina GS et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol 2003;41:1316–1324.PubMedGoogle Scholar
  104. 104.
    Dujardin KS, Enriquez-Sarano M, Schaff HV et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999;99:1851–1857.Google Scholar
  105. 105.
    Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving System. Catheter Cardiovasc Interv 2007;70:760–764.PubMedGoogle Scholar
  106. 106.
    Ussia GP, Barbanti M, Tamburino C. Treatment of severe regurgitation of stentless aortic valve prosthesis with a self-expandable biological valve. J Invasive Cardiol 2009;21:E51–54.PubMedGoogle Scholar
  107. 107.
    Attias D, Himbert D, Brochet E, Laborde JC, Vahanian A. “Valve-in-valve” implantation in a patient with degenerated aortic bioprosthesis and severe regurgitation. Eur Heart J 2009;30:1852.PubMedGoogle Scholar
  108. 108.
    Kelpis TG, Mezilis NE, Ninios VN, Pitsis AA. Minimally invasive transapical aortic valvein-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis. J Thorac Cardiovasc Surg. 2009;138:1018–1020.PubMedGoogle Scholar
  109. 109.
    Bruschi G, Demarco F, Oreglia J et al. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated aortic bioprosthesis. J Cardiovasc Med (Hagerstown) 2010;11:182–185.Google Scholar
  110. 110.
    Maroto LC, Rodríguez JE, Cobiella J, Marcos P. Transapical off-pump aortic valve-in-a-valve implantation in two elderly patients with a degenerated porcine bioprosthesis. Eur J Cardiothorac Surg 2010;37:738–740.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2010

Authors and Affiliations

  • Corrado Tamburino
    • 1
  • Gian Paolo Ussia
    • 2
  1. 1.Ferrarotto HospitalUniversity of Catania, ETNA FoundationCataniaItaly
  2. 2.Cardiology DivisionFerrarotto HospitalCataniaItaly

Personalised recommendations